Patents Assigned to Eleos Pharmaceuticals, Inc.
  • Patent number: 11369664
    Abstract: The present disclosure is concerned with compositions comprising insulin and a pharmaceutically acceptable topical carrier. The present disclosure is also concerned with methods of using these compositions for the treatment of a skin ailment such as a diabetic ulcer. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: June 28, 2022
    Assignee: Eleos Pharmaceuticals, Inc.
    Inventors: Mona E. Buice, David M. Sailors, Joshua Z. Greeson